- $99.05bn
- $153.84bn
- $372.81bn
- 69
- 77
- 96
- 95
Annual income statement for CVS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 268,706 | 292,111 | 322,467 | 357,776 | 372,809 |
| Cost of Revenue | |||||
| Gross Profit | 49,046 | 52,120 | 54,502 | 54,431 | 51,401 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 256,235 | 279,253 | 314,513 | 344,033 | 363,802 |
| Operating Profit | 12,471 | 12,858 | 7,954 | 13,743 | 9,007 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9,770 | 10,537 | 5,836 | 11,173 | 6,148 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7,201 | 7,989 | 4,327 | 8,368 | 4,586 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 7,179 | 8,001 | 4,311 | 8,344 | 4,614 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7,179 | 8,001 | 4,311 | 8,344 | 4,614 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 6.31 | 7.34 | 7.93 | 7.27 | 4.28 |
| Dividends per Share |